Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
Biocon Pharma, a subsidiary of Biocon, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Dapagliflozin Tablets, 5 mg and 10 mg. The…
Indian Pharma Market Grows 7.5% in Feb 2025, But Respiratory Segment Declines by 4.6%
Delhi: The Indian pharmaceutical market (IPM) continued its upward momentum in February 2025, registering a 7.5% monthly growth in value, according to the latest Pharma Trac MAT report. The industry…
Govt considering ban on over 150 combination drugs: Report
NEW DELHI: The government could ban over 150 combination drugs after an expert panel found that those have no therapeutic justification, Mint reported. The Chandrakant Kokate-led expert panel, which was…
